CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes: - Overviews of contentious or emerging issues. - Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses. - Systematic reviews that collate empirical evidence to answer a specific research question| using explicit| systematic methods as outlined by the PRISMA statement. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry. - Original research articles reporting the results of well-designed studies with a strong link to clinical practice| such as clinical pharmacodynamic and pharmacokinetic studies| clinical trials| meta-analyses| outcomes research| and pharmacoeconomic and pharmacoepidemiological studies. Additional digital features (including animated abstracts| video abstracts| slide decks| audio slides| instructional videos| infographics| podcasts and animations) can be published with articles; these are designed to increase the visibility| readership and educational value of the journal’s content. In addition| articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of| but not in-depth expertise in| the area to understand important medical advances.
数据整理自公开网络的投稿反馈，仅供参考。
